Skip to Main Content

Paper Details

Active surveillance versus enzalutamide for low-risk prostate cancer - was it really a trial we needed?
BJU Int
1
2022
Author NameAffiliation
Declan G MurphyPeter MacCallum Cancer Centre
Niall M CorcoranRoyal Melbourne Hospital
Niall M CorcoranUniversity of Melbourne
Damien BoltonUniversity of Melbourne
Damien BoltonAustin Hospital
  • 1 - 5

Datasets

Release 1.2